Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $803.99 | 4 | 36.5% |
| Unspecified | $608.00 | 1 | 27.6% |
| Honoraria | $575.00 | 1 | 26.1% |
| Food and Beverage | $216.95 | 2 | 9.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| National Marrow Donor Program | $1,379 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $608.00 | 1 | $0 (2020) |
| Astellas Pharma US Inc | $117.49 | 1 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $99.46 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,307 | 5 | National Marrow Donor Program ($1,190) |
| 2023 | $189.04 | 1 | National Marrow Donor Program ($189.04) |
| 2020 | $608.00 | 1 | Novartis Pharmaceuticals Corporation ($608.00) |
| 2018 | $99.46 | 1 | Pharmacyclics LLC, An AbbVie Company ($99.46) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $74.00 | General |
| 11/08/2024 | National Marrow Donor Program | — | Honoraria | Cash or cash equivalent | $575.00 | General |
| 11/08/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $336.20 | General |
| 11/08/2024 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $204.75 | General |
| 04/04/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $117.49 | General |
| Category: Oncology | ||||||
| 07/05/2023 | National Marrow Donor Program | — | Travel and Lodging | In-kind items and services | $189.04 | General |
| 04/28/2020 | Novartis Pharmaceuticals Corporation | RYDAPT (Drug) | — | In-kind items and services | $608.00 | Research |
| Study: RESEARCH RELATED PUBLICATIONS SUPPORT • Category: HEMATOLOGY | ||||||
| 02/22/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $99.46 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATIONS SUPPORT | Novartis Pharmaceuticals Corporation | $608.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 16 | 71 | $35,784 | $9,037 |
| 2020 | 1 | 26 | 63 | $31,640 | $5,496 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 71 | $35,784 | $9,037 | 25.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 63 | $31,640 | $5,496 | 17.4% |
About Frederick Appelbaum
Frederick Appelbaum is a Medical Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356426183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Frederick Appelbaum has received a total of $2,204 in payments from pharmaceutical and medical device companies, with $1,307 received in 2024. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Travel and Lodging" ($803.99).
As a Medicare-enrolled provider, Appelbaum has provided services to 42 Medicare beneficiaries, totaling 134 services with total Medicare billing of $14,533. Data is available for 2 years (2020–2021), covering 2 distinct procedure/service records.
Practice Information
- Specialty Medical Oncology
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 12/23/2014
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1356426183
Products in Payments
- RYDAPT (Drug) $608.00
- Xospata (Drug) $117.49
- Imbruvica (Drug) $99.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Seattle
Bart Scott
Medical Oncology — Payments: $1.5M
Petros Grivas, M.d, M.D
Medical Oncology — Payments: $683,103
Evan Yu
Medical Oncology — Payments: $356,321
Gary Lyman, Md, MD
Medical Oncology — Payments: $176,021
Jerald Radich, Md, MD
Medical Oncology — Payments: $171,817
David Maloney
Medical Oncology — Payments: $167,323